Location: | London, Sutton |
---|---|
Salary: | £47,500 to £50,000 per annum |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 27th August 2024 |
---|---|
Closes: | 29th September 2024 |
Key Information
Salary: Commencement on the salary range is subject to comparable skills and experience. Future progression is based on annual performance review.
Duration of Contract: Fixed Term for12 months (Maternity Cover)
Hours per week: 35 hours per week (Full Time)
Job Details
Under the leadership of Prof Chris Jones, we are seeking to appoint a Senior Scientific Officer to to carry out in vitro screening of novel transcription factor-targeting peptides in paediatric high grade glioma models.
The Glioma Team at the ICR is focussed on understanding the biology of paediatric high grade glioma, such that we may improve the clinical outcome of children with these currently untreatable tumours.
We have a short term position (12 months) available for an in vitro scientist to provide maternity cover for an ongoing project exploring the use of novel transcription factor-targeting peptides to disrupt tumorigenic phenotypes. We are looking for someone with experience in cancer cell culture and a range of molecular biology techniques. At a minimum you will be expected to run assays with these peptides to assess cell permeability, effects on cell viability and invasion/migration, and the impact on downstream signalling pathways. For a more experienced candidate, there are a number of other areas of work involving co-culture cell-cell interactions, epigenetic profiling, and drug screening that you could also be involved in. The role will require regular updates to be provided to our commercial partner, but also affords the opportunity to generate highly publishable data within a short time-frame. We will consider postdocs but also experienced scientists without a PhD.
Key Requirements
The successful candidate must have experience in cancer cell culture, cell viability, invasion/ migration assays and experience with in vitro experiment management and use of analytical software for drug assays. Please refer to the job description for more details of the key requirements of the role.
Department/Directorate Information:
The Division of Molecular Pathology is focused on understanding the molecular alterations important in the development and progression of cancer, and in determining how the disease responds to treatment. The goal is to translate advances in the molecular characterisation of tumours into approaches to successfully implement personalised cancer treatment.
We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Chris Jones via Email at chris.jones@icr.ac.uk.
About The Institute of Cancer Research
Why work for us?
As a member of staff, you'll have exclusive access to a range of staff benefits.
The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.
The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.
We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.
Type / Role:
Subject Area(s):
Location(s):